Showing results (3241-3250 of 3,354) with videos related to

Sort By:
Pageof 336
Pharmacoeconomics|November 29, 2025
Economic Evaluations of Medication Safety Interventions in Primary and Long-Term Care: A Systematic ReviewSneha T Amritlal, Rosalyn Chandler, Alireza Mahboub-Ahari, et al.
Pharmacoeconomics|November 19, 2025
Model-Based Economic Evaluation of the First-in-Class Myosin Inhibitor Mavacamten Versus Care as Usual in Obstructive Hypertrophic Cardiomyopathy Patients from a Dutch Societal PerspectiveIsabell Wiethoff, Willem J A Witlox, Silvia M A A Evers, et al.
Pharmacoeconomics|November 21, 2025
The 'Values in Modelling' Framework for Patient and Public Involvement in Health Economics Modelling: Development and Application in the LEAP Model ProjectStephanie Harvard, Rachel Carter, Sian Hoe Cheong, et al.
Pharmacoeconomics|November 28, 2025
Beyond the States: Developing a Discrete Event Simulation Model Using RZiyi Lin, Andrew Briggs
Pharmacoeconomics|February 11, 2025
Examining Consistency Across NICE Single Technology Appraisals: A Review of Appraisals for Paroxysmal Nocturnal HaemoglobinuriaJeremiah Donoghue, Matthew Youngs, Alex Reeve, et al.
Pharmacoeconomics|January 3, 2025
Cost Effectiveness of Exclusionary EGFR Testing for Taiwanese Patients Newly Diagnosed with Advanced Lung AdenocarcinomaHuang-Tz Ou, Jui-Hung Tsai, Yi-Lin Chen, et al.
Pharmacoeconomics|December 2, 2023
Recommendations for Emerging Good Practice and Future Research in Relation to Family and Caregiver Health Spillovers in Health Economic Evaluations: A Report of the SHEER Task ForceEdward Henry, Hareth Al-Janabi, Werner Brouwer, et al.
Pharmacoeconomics|February 13, 2024
Exploring the Use of Pictorial Approaches in the Development of Paediatric Patient-Reported Outcome Instruments: A Systematic ReviewChristine Mpundu-Kaambwa, Norma B Bulamu, Lauren Lines, et al.
Pharmacoeconomics|February 4, 2024
Incorporating Real Option Value in Valuing Innovation: A Way ForwardMeng Li, Louis P Garrison
Pharmacoeconomics|January 18, 2024
Psychometric Performance Comparison of the Adapted versus Original Versions of the EQ-5D-Y-3L and -Y-5L in Proxy Respondents for 2- to 4-Year-OldsAlexander van Heusden, Oliver Rivero-Arias, Michael Herdman, et al.
Pageof 336